يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"PROTEIN overexpression"', وقت الاستعلام: 0.74s تنقيح النتائج
  1. 1
    تقرير
    Adjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal Junction

    المؤلفون: AstraZeneca

    المصدر: BrUOG 413: A Phase II Study of Adjuvant Trastuzumab Deruxtecan (Enhertu) + Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2-Positive Cancers of the Esophagus and Gastroesophageal Junction

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05480384Test

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
  2. 2
    تقرير
    HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma

    المؤلفون: Center for Cell and Gene Therapy, Baylor College of Medicine, The Faris Foundation USA, Stand Up To Cancer, Triumph Over Kid Cancer Foundation, St. Baldrick's Foundation, National Cancer Institute (NCI)

    المساهمون: Meenakshi Hegde, M.D., Associate Professor

    المصدر: Phase I Study of HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma (HEROS 3.0)

    الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04995003Test

    Other URLs: https://rarediseases.info.nih.govTest/

    View record in ClinicalTrials.gov

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث